Tingting Jiang

Title: Innovations of Tingting Jiang in Cancer Detection

Introduction

Tingting Jiang is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of cancer detection through her innovative research and development. With a total of 5 patents, her work focuses on utilizing cell-free DNA to improve the accuracy of tumor variant detection.

Latest Patents

One of her latest patents is titled "Using cell-free DNA fragment size to detect tumor-associated variant." This patent outlines methods and systems for determining a variant of interest by analyzing sizes and sequences of cfDNA fragments obtained from a test sample. The processes described in this patent synergistically combine size and sequence information, thereby enhancing the specificity and sensitivity of assays compared to conventional methods. Another notable patent is "Fragment size characterization of cell-free DNA mutations from clonal hematopoiesis." This invention provides methods and systems for differentiating between cancer variants and somatic variants originating from hematopoietic cells in a cell-free DNA sample. In certain embodiments, the cancer variants can be distinguished from somatic variants based on fragment size distribution.

Career Highlights

Tingting Jiang is currently employed at Illumina Corporation, a leading company in the field of genomics. Her work at Illumina has allowed her to push the boundaries of cancer research and develop innovative solutions that can potentially save lives.

Collaborations

Tingting has collaborated with notable colleagues such as Chen Zhao and Han-Yu Chuang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Tingting Jiang's contributions to cancer detection through her patents and work at Illumina Corporation highlight her role as a leading inventor in the field. Her innovative approaches to analyzing cell-free DNA are paving the way for more accurate and effective cancer diagnostics.